ArticleCancers2023

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.

Hsueh-Chien Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.